1. Princess Margaret Cancer Centre integrated molecular profiling in advanced cancers trial (IMPACT) using genotyping and targeted next-generation sequencing.;Bedard;J. Clin. Oncol.,2013
2. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.;Chen;Lung Cancer,2011
3. Clinical application of molecular profiling in selecting treatment for advanced refractory and rare solid tumours: an Australian experience. Abstract 955 presented at ECCO.;Dean,2013
4. Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated with either single-agent doxorubicin or single-agent docetaxel.;Durbecq;Mol. Cancer Ther.,2004
5. Current methods of the US Preventive Services Task Force: a review of the process.;Harris;Am. J. Prev. Med.,2001